Navigation Links
Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells
Date:2/4/2008

tein-folding and aggregation diseases as well, like Parkinson's and Alzheimer's," Mu said.

Ernest Beutler, chair of the Department of Molecular and Experimental Medicine at The Scripps Research Institute and an expert on Gaucher disease, is currently developing animal models of neuropathic Gaucher disease that Kelly and his colleagues hope to utilize in collaboration with the Beutler group to further evaluate the utility of diltiazem, verapamil, and their analogs.


'/>"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
Source:Eurekalert

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Scripps Research scientists shed new light on how antibodies fight HIV
2. Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County
3. Scripps research scientists discover chemical triggers for aggression in mice
4. Scripps research scientists find new genetic mutation that halts the development of lupus
5. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
6. Scientists Probe Sepsis Deadly Secrets
7. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
8. Scientists Develop Natural Protection for Stored Foods
9. Scientists detect presence of marburg virus in african fruit bats
10. Scientists Spot Brains Free Will Center
11. Scientists ID Likely Culprit in Popcorn Lung
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...N, Dec. 4 The American Association of Homes and S...for ensuring that the Community Living and Suppor...al health reform legislation . The CLASS provision...eople with disabilities and their caregivers. ,, ...ll that will make it affordable to care for famili...
(Date:12/4/2009)...CITY, Mo., Dec. 4 The large, two-day free health ...ee Clinics (NAFC) in Kansas City on Wednesday and ...one who is uninsured and has not seen a doctor rec...receive preventive primary care. ,, "Many people ...events this fall in Houston, New Orleans and Littl...
(Date:12/4/2009)...M, Calif., Dec. 4 Pamela Bowen, Chief Information... finalist for the "Chief Innovation Officer" Appy ...e power of cloud computing. Appy Award recipients ...alesforce CRM or the Force.com platform in bringin...arketing, partner, service, support or IT organiza...
(Date:12/4/2009)...TON, Dec. 4 In response to the U.S. Justice Depar...on of boldione, desoxymethyltestosterone, and 19-n...s", under the Controlled Substances Act (CSA), Joh...roducts Association (NPA), the oldest and largest ...facturers of dietary supplements and other natural...
(Date:12/4/2009)..., Calif. A new study shows that muscle cells grow... squeeze shut properly. The work, performed in dog...ith conditions such as gastric reflux and fecal in...gthen sphincters, which are the bands of muscle th...tract. Weakness in these areas can cause gastroint...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
...ght on the mechanism of nerve cell growth by ident...tein, myosin-II, according to an //article in the ...ls develop or attempt to recover after damage, the... the nerve cells and it has long been known that s...
...omi Adajania's English film "Being Cyrus" coming u... older women in roles that explore their sexual si...film features Dimple Kapadia as Katy, a Parsi woma...l of movies like "Freaky Chakra", "Leela", "Dil Ch...
...oday developed a new drill to help with the keyhol...rgery for// cervical spondylitis and disk prolapse... department of neurosurgery at King George's Medic... The central commerce ministry has awarded a pat...
...scare deters the Bhopal residents from relishing t...hicken prices, the people, specifically in the old...st of chicken. 'No doubt, the sale of chicke..., who resides in the Budhwara locality of the old ...
...I-M) leader, Brinda Karat has been issued a legal ... produced at Ramdev's pharmacy were contaminated w... The notice issued on behalf of B.D. Sethi, a ...' The notice, which comes after the Uttaranc...
...ng their emotional pain by taking Oxycontin, a pre... dose they turn to heroin as a cheaper option. // ...of American children getting addicted to prescript... medicine cabinets. Health officials say that...
Other Medicine News:Health News:A New Focus For The Mechanism Of Nerve Growth 2Health News:Needed, more space for women's sexual identity on marquees 2Health News:Needed, more space for women's sexual identity on marquees 3Health News:Needed, more space for women's sexual identity on marquees 4Health News:New Generation Teenagers Addiction to Prescription Drugs 2
(Date:12/4/2009)... , HOUSTON, Dec. 4 OrthoAccel Techn...m , which is an acceleration device to enhance ort...tinuing Education course published by PennWell Co... many industries, including medicine and dentistry...dontic treatment, a summary of treatment biomechan...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: ...ministration (FDA) has approved once-daily SEROQUE...Tablets as adjunctive (add-on) treatment to antide... (MDD). SEROQUEL XR is the only medication in its ...essive disorder as adjunctive therapy and acute de...
(Date:12/3/2009)... , MADISON, N.J., Dec. 3 A genetic variation that...entially life-threatening blood disorder if expose... is one of several medical discoveries scientists ...SE: DGX ) will present during the 51st American ...osition, December 5-8, 2009, in New Orleans, LA. ...
Breaking Medicine Technology:AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Clinical Trial by Licensee Does Not Meet Primary Endpoint 53294 1Clinical Trial by Licensee Does Not Meet Primary Endpoint 53294 2Solta Medical Reports Strong Second Quarter 2009 Results 53291 1Solta Medical Reports Strong Second Quarter 2009 Results 53291 2Solta Medical Reports Strong Second Quarter 2009 Results 53291 3Solta Medical Reports Strong Second Quarter 2009 Results 53291 4Solta Medical Reports Strong Second Quarter 2009 Results 53291 5Solta Medical Reports Strong Second Quarter 2009 Results 53291 6Solta Medical Reports Strong Second Quarter 2009 Results 53291 7Solta Medical Reports Strong Second Quarter 2009 Results 53291 8Solta Medical Reports Strong Second Quarter 2009 Results 53291 9Solta Medical Reports Strong Second Quarter 2009 Results 53291 10Solta Medical Reports Strong Second Quarter 2009 Results 53291 11Nephros Inc Completes 241 25 Million Private Placement 53287 1Nephros Inc Completes 241 25 Million Private Placement 53287 2Nephros Inc Completes 241 25 Million Private Placement 53287 3
...ology Society Annual Meeting -, SOUTH PLAINFIELD,...opharmaceutical company focused on the discovery, ...e drugs targeting,post-transcriptional control mec...y data from a Phase 2 clinical trial of PTC124 in ...e to a nonsense mutation. The results,which includ...
...rapeutics,Inc. (OTC Bulletin Board: NILT), today a... CD-NP, Nile,s selective NPR-B agonist being devel...ts of this study will be included,in the Company,s...an,Francisco, CA. "The development of a peptide t...ely little effect on blood pressure, is a potentia...
Other Medicine Technology:PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure 2UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure 3UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure 4
Deluxe
Wraparound Apron & Vest
Special Procedure Apron
Coat Apron
Medicine Products: